Mefruside

Jump to: navigation, search
Mefruside
Mefruside.png
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H19ClN2O5S2
Molar mass382.88 g/mol
3D model (JSmol)

WikiDoc Resources for Mefruside

Articles

Most recent articles on Mefruside

Most cited articles on Mefruside

Review articles on Mefruside

Articles on Mefruside in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mefruside

Images of Mefruside

Photos of Mefruside

Podcasts & MP3s on Mefruside

Videos on Mefruside

Evidence Based Medicine

Cochrane Collaboration on Mefruside

Bandolier on Mefruside

TRIP on Mefruside

Clinical Trials

Ongoing Trials on Mefruside at Clinical Trials.gov

Trial results on Mefruside

Clinical Trials on Mefruside at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mefruside

NICE Guidance on Mefruside

NHS PRODIGY Guidance

FDA on Mefruside

CDC on Mefruside

Books

Books on Mefruside

News

Mefruside in the news

Be alerted to news on Mefruside

News trends on Mefruside

Commentary

Blogs on Mefruside

Definitions

Definitions of Mefruside

Patient Resources / Community

Patient resources on Mefruside

Discussion groups on Mefruside

Patient Handouts on Mefruside

Directions to Hospitals Treating Mefruside

Risk calculators and risk factors for Mefruside

Healthcare Provider Resources

Symptoms of Mefruside

Causes & Risk Factors for Mefruside

Diagnostic studies for Mefruside

Treatment of Mefruside

Continuing Medical Education (CME)

CME Programs on Mefruside

International

Mefruside en Espanol

Mefruside en Francais

Business

Mefruside in the Marketplace

Patents on Mefruside

Experimental / Informatics

List of terms related to Mefruside

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.[1]

It was developed by Bayer A.G. and is sold under the tradename Baycaron.

References

  1. Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. PMID 4779251.

Linked-in.jpg